The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.
COVID-19 Clinical Forum 2023
Related Enduring Materials
Enduring Materials
Tuesday, 7 March -
Clinical, Public Health, and Behavioral Aspects of COVID-19 in China and Implications for the World
Global Burden of Long COVID
Update on COVID-19 Therapeutics
Tuesday, 16 May -
Kathryn Stephenson, MD, MPH
Penny Moore, PhD
COVID -19 Prevention - Do We Need Subtype Specific Vaccines?
Harvard Medical School / Ragon Institute / Beth Israel Deaconess Medical Center, United States
Hybrid Immunity to SARS-CoV2 – The New Normal
University of the Witwatersrand / National Institute for Communicable Diseases, South Africa
Update on COVID-19 Therapeutics
Tuesday, 3 October -
Kathryn Stephenson, MD, MPH
Updated Recommendations for SARS-CoV-2 Vaccination
Harvard Medical School / Ragon Institute / Beth Israel Deaconess Medical Center, United States
Update on COVID-19 Therapeutics
Nirmatrelvir/ritonavir for the Treatment of Long COVID
Thursday, 14 December -
Penny Moore, PhD
COVID-19 and the Immunosuppressed Patient
The Impact of New Variants on Global Epidemiology, Disease Acquisition, and Progression
University of the Witwatersrand / National Institute for Communicable Diseases, South Africa
Update on COVID-19 Therapeutics
Overview
Image
Thank you
We are pleased to reflect on the highly successful webinar series for the COVID-19 Clinical Forum in 2023.
The Program Directors and organizers would like to thank the speakers, chairs, and all participants for their contribution to this meeting!
Special thanks to the webinar supporter: MSD and Pfizer. Without their contribution, this webinar would not have been made possible.
About this Program
The COVID-19 Clinical Forum 2023 is a series of 4 online interactive meetings (90 minutes each) that provide continuing education to a wide range of healthcare professionals, including infectious disease doctors, pulmonologists, and virologists.
The program encompasses a broad range of topics, from COVID-19 epidemiology, treatments, post-COVID conditions & clinical manifestations, clinical management, pathophysiology, prevention, vaccines, to diagnostics and public health strategies.
This program is continuously updated as new information emerges and provides the latest COVID-19 data from renowned experts to clinicians worldwide. The program is designed to provide state-of-the-art, concise, and comprehensive lectures, and to facilitate participation from healthcare professionals from around the world.
Program Directors
General Information
Topics of Interest
The program will encompass a wide range of topics, from vaccine research, immune response, SARS CoV-2 infection, diagnostics, and the use of artificial intelligence to contain the spread of the virus, to clinically orientated lectures on emerging treatment options and novel insights into disease pathophysiology.
The series will include continuous updates on COVID-19 infection control, epidemiology, prevention, diagnosis, pathogenesis, pathophysiology, clinical manifestations and management, emerging variants, therapeutic options, vaccine development and Implementation, public health measures, and treatments.
The series will include continuous updates on COVID-19 infection control, epidemiology, prevention, diagnosis, pathogenesis, pathophysiology, clinical manifestations and management, emerging variants, therapeutic options, vaccine development and Implementation, public health measures, and treatments.
Who Should Attend?
-Healthcare providers;
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Intensivists;
-Researchers;
-Nurses;
-Pharmacists;
-Others interested in staying informed on new insights and developments.
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Intensivists;
-Researchers;
-Nurses;
-Pharmacists;
-Others interested in staying informed on new insights and developments.
Practical Information
We trust that the following information will assist you in organizing your participation for the COVID-19 Clinical Forum 2023 webinar series.
Schedule
-Tuesday, 7 March 2023 at 20:00 CET / 14:00 EST
-Tuesday, 16 May 2023 at 20:00 CEST / 14:00 EDT
-Tuesday, 3 October 2023 at 20:00 CEST / 14:00 EDT
-Thursday, 14 December 2023 at 20:00 CET / 15:00 EDT
-Tuesday, 16 May 2023 at 20:00 CEST / 14:00 EDT
-Tuesday, 3 October 2023 at 20:00 CEST / 14:00 EDT
-Thursday, 14 December 2023 at 20:00 CET / 15:00 EDT
Certificate of Attendance
A digital certificate of attendance will be sent to participants that have successfully completed the program and post-meeting survey.
Language
The official language of the webinar is English. Translation will not be provided.
Liability & Insurance
By registering for the webinar, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Support
The COVID-19 Clinical Forum 2023 was supported by a grant from MSD. MSD has had no input into the selection of speakers or the content of the materials and presentations.
The March, May, and October editions of the COVID-19 Clinical Forum 2023 was supported by a grant from Pfizer Inc.
Endorsers
The COVID-19 Clinical Forum 2023 webinar series was endorsed by the following organizations:
Language
